Brady Releases Labeling System Designed for Labs
Brady introduces Labxpert v2.0 model to fulfill labeling requirements of the lab.
Oxfordshire, UK-May 13, 2008-Brady's (www.bradylab.co.uk) Labxpert™ labeling system was specifically designed for the labeling requirements of the modern laboratory and is capable of producing clear, permanent labels for virtually any laboratory application-flasks, tubes, straws, microplates and microscope slides, to name only a few.
The Labxpert’s 300dpi resolution printing means that even the smallest fonts and barcodes can be printed with complete clarity and legibility. More than 140 lab-specific symbols (Greek, scientific, and safety symbols) are instantly available for added convenience. This compact, lightweight (less than 1Kg), hand-held device can produce labels 80% faster than hand-writing-and with font sizes down to 1mm, far more information can be included than on any hand-written label. The innovative “Drop, Lock, and Print” Smart Cartridge makes it quick and easy to change between different labeling jobs.
However, Brady points out that in laboratory labeling the printer, however good, is only part of the story. It is when the Labxpert is combined with the unique range of specialized label materials and print media available from Brady that a solution will be found for virtually any laboratory labeling task. Labels can be produced that will withstand the harshest environments-temperatures from liquid nitrogen (-196°C) to autoclave (+121°C), and solvents like Xylene, Ethanol, DMSO, and IPA-and that will remain intact and legible through many cycles of immersion and repeated handling. Brady Freezerbondz II labels can even be applied to already frozen surfaces.
According to Brady, the latest Labxpert v2.0 model has a USB port for easy PC connectivity, plus narrower bar codes and 10 new font sizes to fit more information on the very small labels needed for some laboratory consumables. The optional IdentiLab™ PC software has easy-to-use wizards for label creation and tools for more advanced applications such as database import, automatic text formatting, multi-label data entry, and 2-D bar codes.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
